Business ❯Pharmaceutical Industry

Mergers and Acquisitions

Gilead Sciences Contract Manufacturing Market Competition Sanofi AstraZeneca Bristol Myers Squibb AstraZeneca Acquisitions

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

The deal, which could reach $2 billion with milestones, positions GSK to target unmet needs in liver disease with a planned 2029 launch.

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal